Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Press release

Zapata Quantum to Present at the Global Technology Virtual Investor Conference July 9th

Share

CEO Sumit Kapur will discuss highlights including the Company's NVIDIA collaboration and quantum cancer research recognized as a Nature Biotechnology Top 10

BOSTON, Massachusetts – July 7, 2026 – Zapata Quantum (OTCQB: ZPTA) (“Zapata” or the “Company”) today announced that its CEO, Sumit Kapur, will present live at the Global Technology Virtual Investor Conference hosted by Virtual Investor Conferences and OTC Markets this Thursday, July 9, 2026.

Date: July 9

Time: 10:30 a.m. ET

Link: Zapata Quantum’s Presentation

Kapur will be available for one-on-one meetings on July 10 from 10 a.m. to 12 p.m. ET, and July 14 from 11 a.m. to 1 p.m. ET. Scheduling is available through this link.

This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are unable to join the event live on the day of the conference, an archived webcast will also be made available after the event.

It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates.

Learn more about the event at www.virtualinvestorconferences.com.

Recent Company Highlights

  • Collaboration with NVIDIA to apply agentic AI to accelerate quantum algorithm development: The initiative targets the creation of a scalable automated system for quantum resource estimation, a major bottleneck in quantum application development.
  • Groundbreaking quantum-enabled drug discovery research recognized as one of the Top 10 Papers of 2025 by Nature Biotechnology: The study, co-authored with Dana-Farber Cancer Institute, University of Toronto, and Insilico Medicine, provides a proof point of Zapata’s capabilities and quantum computing’s transformative potential to generate viable drug candidates in the biotech domain.
  • Successful restructuring capped by $15 million fundraise led by Triatomic Capital: The Company has also expanded its leadership team with quantum software pioneers including Yudong Cao, former Head of Quantum at BCG X, as CTO.

About Virtual Investor Conferences®

Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.

Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.

About Zapata Quantum

Zapata Quantum is a leading hardware-agnostic, pure-play quantum software company focused on accelerating quantum application development. With a portfolio of more than 60 granted and pending patents developed over seven years, Zapata supports applications across cryptography, pharmaceuticals, finance, materials discovery, defense, and more. The Company is the only organization to have participated across all technical areas of DARPA’s Quantum Benchmarking program and has worked with Fortune 500 enterprises and government agencies to translate quantum advances into real-world impact. The Company’s study demonstrating the potential of quantum-enabled drug discovery was recognized as one of Nature Biotechnology’s Top 10 Papers of 2025. For more information, visit ZapataQuantum.com.

CONTACTS:

HKA Marketing Communications

Taylor White

Account Manager

(714) 426-0444

taylor@hkamarcom.com

Virtual Investor Conferences

Greg Young


VP Corporate Services


OTC Markets Group


(212) 652-5958


greg@otcmarkets.com

Source: Zapata Quantum Inc. This release was filed with the U.S. Securities and Exchange Commission on Jul 7, 2026 and is reproduced here as issued. View the filing.

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.